Skip to main content
Erschienen in: World Journal of Urology 5/2013

01.10.2013 | Topic Paper

Gender differences in benign renal masses

verfasst von: Julian Mauermann, Michela de Martino, Matthias Waldert, Andrea Haitel, Hans Christoph Klingler, Mesut Remzi, Tobias Klatte

Erschienen in: World Journal of Urology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine gender-specific differences in benign renal tumors.

Methods

This retrospective study included 135 adult Caucasian patients with 143 benign renal tumors, which were treated surgically at a single institution. Demographics, comorbidity, histology, renal function, and management were compared by gender. A systematic review and meta-analysis of the literature were performed.

Results

A total of 73 women were compared with 62 men. The female-to-male ratio was significantly higher in patients with benign renal tumors than in those with renal cell carcinoma (1.18:1 vs. 0.57:1, p < 0.001). Only 17 % of benign renal tumors were correctly classified by preoperative computed tomography. The most frequently observed histological types were oncocytoma (44 %) and angiomyolipoma (37 %). Angiomyolipoma occurred more than twice as often in women than in men (72 vs. 28 %), while oncocytoma was more frequently found in men (59 vs. 41 %, p = 0.001). Men with benign renal tumors were older (p = 0.002) and had higher body mass indices (p = 0.019), higher comorbidity indices (p < 0.001), lower ECOG performance status (p < 0.001), and smaller tumors (p = 0.045). No differences were seen in pack years, mode of diagnosis, bilaterality, renal function, use of laparoscopic surgery, and the rate of radical nephrectomy. In the meta-analysis of 9,665 renal tumors, women had a 2.55-fold increased chance of benign pathology and a greater chance of angiomyolipoma (OR 4.66) than men.

Conclusions

This study demonstrated several gender-specific differences in benign renal tumors, especially in the histological types. Despite this, clinical–pathological features and management of benign renal tumors in men and women appear more alike than different.
Literatur
1.
Zurück zum Zitat Simard EP, Ward EM, Siegel R, Jemal A (2012) Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. doi:10.3322/caac.20141 Simard EP, Ward EM, Siegel R, Jemal A (2012) Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. doi:10.​3322/​caac.​20141
2.
Zurück zum Zitat Murphy AM, Buck AM, Benson MC, McKiernan JM (2009) Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology 73:1293–1297PubMedCrossRef Murphy AM, Buck AM, Benson MC, McKiernan JM (2009) Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology 73:1293–1297PubMedCrossRef
3.
Zurück zum Zitat Schmidbauer J, Remzi M, Memarsadeghi M, Haitel A, Klingler HC, Katzenbeisser D, Wiener H, Marberger M (2008) Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 53:1003–1011PubMedCrossRef Schmidbauer J, Remzi M, Memarsadeghi M, Haitel A, Klingler HC, Katzenbeisser D, Wiener H, Marberger M (2008) Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 53:1003–1011PubMedCrossRef
4.
Zurück zum Zitat Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, Remzi M, Uzzo RG (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62:491–504PubMedCrossRef Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, Remzi M, Uzzo RG (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62:491–504PubMedCrossRef
5.
Zurück zum Zitat Margulis V, Matin SF, Wood CG (2012) Benign renal tumors. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-walsh urology, vol 2, 10th edn. Elsevier Saunders, Philadelphia, pp 1492–1505CrossRef Margulis V, Matin SF, Wood CG (2012) Benign renal tumors. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-walsh urology, vol 2, 10th edn. Elsevier Saunders, Philadelphia, pp 1492–1505CrossRef
6.
Zurück zum Zitat Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC, Campbell SC (2008) Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 180:836–843PubMedCrossRef Lane BR, Aydin H, Danforth TL, Zhou M, Remer EM, Novick AC, Campbell SC (2008) Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 180:836–843PubMedCrossRef
7.
Zurück zum Zitat Remzi M, Katzenbeisser D, Waldert M, Klingler HC, Susani M, Memarsadeghi M, Heinz-Peer G, Haitel A, Herwig R, Marberger M (2007) Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int 99:1002–1006PubMedCrossRef Remzi M, Katzenbeisser D, Waldert M, Klingler HC, Susani M, Memarsadeghi M, Heinz-Peer G, Haitel A, Herwig R, Marberger M (2007) Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int 99:1002–1006PubMedCrossRef
8.
Zurück zum Zitat Jeon HG, Lee SR, Kim KH, Oh YT, Cho NH, Rha KH, Yang SC, Han WK (2010) Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients. Urology 76:574–579PubMedCrossRef Jeon HG, Lee SR, Kim KH, Oh YT, Cho NH, Rha KH, Yang SC, Han WK (2010) Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients. Urology 76:574–579PubMedCrossRef
9.
Zurück zum Zitat Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef
10.
Zurück zum Zitat Klatte T, Grubmüller B, Waldert M, Weibl P, Remzi M (2011) Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol 60:435–443PubMedCrossRef Klatte T, Grubmüller B, Waldert M, Weibl P, Remzi M (2011) Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol 60:435–443PubMedCrossRef
11.
Zurück zum Zitat Romis L, Cindolo L, Patard JJ, Messina G, Altieri V, Salomon L, Abbou CC, Chopin D, Lobel B, de La Taille A (2004) Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol 45:53–57 (discussion 57)PubMedCrossRef Romis L, Cindolo L, Patard JJ, Messina G, Altieri V, Salomon L, Abbou CC, Chopin D, Lobel B, de La Taille A (2004) Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol 45:53–57 (discussion 57)PubMedCrossRef
12.
Zurück zum Zitat Aron M, Nguyen MM, Stein RJ, Gill IS (2008) Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 54:133–140PubMedCrossRef Aron M, Nguyen MM, Stein RJ, Gill IS (2008) Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 54:133–140PubMedCrossRef
13.
Zurück zum Zitat McCauley LR, Beckham CJ, Hunter TB, Nguyen MM (2010) Gender and renal cancer: do variations in clinical presentation and imaging patterns explain observed differences between males and females? Urology 76:536–540PubMedCrossRef McCauley LR, Beckham CJ, Hunter TB, Nguyen MM (2010) Gender and renal cancer: do variations in clinical presentation and imaging patterns explain observed differences between males and females? Urology 76:536–540PubMedCrossRef
14.
Zurück zum Zitat Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR (2008) Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 179:1704–1708PubMedCrossRef Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR (2008) Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 179:1704–1708PubMedCrossRef
15.
Zurück zum Zitat Eble JN, Togashi K, Pisani P, Sauter G, Epstein JI, Sesterhenn IA (2004) Tumours of the Kidney. In: World health organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 9–87 Eble JN, Togashi K, Pisani P, Sauter G, Epstein JI, Sesterhenn IA (2004) Tumours of the Kidney. In: World health organization classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 9–87
16.
Zurück zum Zitat Lane BR, Poggio ED, Herts BR, Novick AC, Campbell SC (2009) Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol 182:435–444PubMedCrossRef Lane BR, Poggio ED, Herts BR, Novick AC, Campbell SC (2009) Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol 182:435–444PubMedCrossRef
17.
Zurück zum Zitat Waldert M, Klatte T, Haitel A, Ozsoy M, Schmidbauer J, Marberger M, Remzi M (2010) Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57:661–666PubMedCrossRef Waldert M, Klatte T, Haitel A, Ozsoy M, Schmidbauer J, Marberger M, Remzi M (2010) Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57:661–666PubMedCrossRef
18.
Zurück zum Zitat Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P (2006) Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176:2391–2396PubMedCrossRef Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P (2006) Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176:2391–2396PubMedCrossRef
19.
Zurück zum Zitat Zisman A, Patard JJ, Raz O, Klatte T, Haifler M, Mendlovic S, Sandbank J, Belldegrun AS, Lindner A, Leibovici D, Pantuck AJ (2010) Sex, age, and surgeon decision on nephron-sparing surgery are independent predictors of renal masses with benign histologic findings–a multicenter survey. Urology 76:541–546PubMedCrossRef Zisman A, Patard JJ, Raz O, Klatte T, Haifler M, Mendlovic S, Sandbank J, Belldegrun AS, Lindner A, Leibovici D, Pantuck AJ (2010) Sex, age, and surgeon decision on nephron-sparing surgery are independent predictors of renal masses with benign histologic findings–a multicenter survey. Urology 76:541–546PubMedCrossRef
20.
Zurück zum Zitat Tsivian M, Mouraviev V, Albala DM, Caso JR, Robertson CN, Madden JF, Polascik TJ (2011) Clinical predictors of renal mass pathological features. BJU Int 107:735–740PubMedCrossRef Tsivian M, Mouraviev V, Albala DM, Caso JR, Robertson CN, Madden JF, Polascik TJ (2011) Clinical predictors of renal mass pathological features. BJU Int 107:735–740PubMedCrossRef
21.
Zurück zum Zitat Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG (2011) Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol 60:241–248PubMedCrossRef Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG (2011) Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol 60:241–248PubMedCrossRef
22.
Zurück zum Zitat Kava BR, Eldefrawy A, Ayyathurai R, Manoharan M, Aziz M, Bird VG, Katkoori D, Ramanathan R, Jorda M, Ciancio G, Soloway MS, Leveillee RJ (2012) Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgery. Int Urol Nephrol 44:1319–1324PubMedCrossRef Kava BR, Eldefrawy A, Ayyathurai R, Manoharan M, Aziz M, Bird VG, Katkoori D, Ramanathan R, Jorda M, Ciancio G, Soloway MS, Leveillee RJ (2012) Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgery. Int Urol Nephrol 44:1319–1324PubMedCrossRef
23.
Zurück zum Zitat Ligato S, Ro JY, Tamboli P, Amin MB, Ayala AG (1999) Benign tumors and tumor-like lesions of the adult kidney. Part I: benign renal epithelial neoplasms. Adv Anat Pathol 6:1–11PubMedCrossRef Ligato S, Ro JY, Tamboli P, Amin MB, Ayala AG (1999) Benign tumors and tumor-like lesions of the adult kidney. Part I: benign renal epithelial neoplasms. Adv Anat Pathol 6:1–11PubMedCrossRef
24.
Zurück zum Zitat Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Kwon ED, Leibovich BC (2008) Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Urology 72:927–932PubMedCrossRef Boorjian SA, Sheinin Y, Crispen PL, Lohse CM, Kwon ED, Leibovich BC (2008) Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Urology 72:927–932PubMedCrossRef
25.
Zurück zum Zitat Lane BR, Campbell SC, Remer EM, Fergany AF, Williams SB, Novick AC, Weight CJ, Magi-Galluzzi C, Zhou M (2008) Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics. Urology 71:1142–1148PubMedCrossRef Lane BR, Campbell SC, Remer EM, Fergany AF, Williams SB, Novick AC, Weight CJ, Magi-Galluzzi C, Zhou M (2008) Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics. Urology 71:1142–1148PubMedCrossRef
26.
Zurück zum Zitat de Martino M, Böhm M, Klatte T (2012) Malignant solitary fibrous tumour of the kidney: report of a case and cumulative analysis of the literature. Aktuelle Urol 43:59–62PubMedCrossRef de Martino M, Böhm M, Klatte T (2012) Malignant solitary fibrous tumour of the kidney: report of a case and cumulative analysis of the literature. Aktuelle Urol 43:59–62PubMedCrossRef
27.
Zurück zum Zitat Akdogan B, Gudeloglu A, Inci K, Gunay LM, Koni A, Ozen H (2012) Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma. Clin Genitourin Cancer 10:121–125 Akdogan B, Gudeloglu A, Inci K, Gunay LM, Koni A, Ozen H (2012) Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma. Clin Genitourin Cancer 10:121–125
28.
Zurück zum Zitat Mullins JK, Kaouk JH, Bhayani S, Rogers CG, Stifelman MD, Pierorazio PM, Tanagho YS, Hillyer SP, Kaczmarek BF, Chiu Y, Allaf ME (2012) Tumor complexity predicts malignant disease for small renal masses. J Urol 188:2072–2076 Mullins JK, Kaouk JH, Bhayani S, Rogers CG, Stifelman MD, Pierorazio PM, Tanagho YS, Hillyer SP, Kaczmarek BF, Chiu Y, Allaf ME (2012) Tumor complexity predicts malignant disease for small renal masses. J Urol 188:2072–2076
29.
Zurück zum Zitat Park SY, Jeon SS, Lee SY, Jeong BC, Seo SI, Lee HM, Choi HY (2011) Incidence and predictive factors of benign renal lesions in Korean patients with preoperative imaging diagnoses of renal cell carcinoma. J Korean Med Sci 26:360–364 Park SY, Jeon SS, Lee SY, Jeong BC, Seo SI, Lee HM, Choi HY (2011) Incidence and predictive factors of benign renal lesions in Korean patients with preoperative imaging diagnoses of renal cell carcinoma. J Korean Med Sci 26:360–364
30.
Zurück zum Zitat Hsieh PF, Chang CH, Huang CP, Chen CC, Chen KL, Chang SS, Yeh CC, Chen WC, Chou CL, Wu HC (2012) The impact of gender and size on the pathology of small renal mass. Kaohsiung J Med Sci 28:369–372 Hsieh PF, Chang CH, Huang CP, Chen CC, Chen KL, Chang SS, Yeh CC, Chen WC, Chou CL, Wu HC (2012) The impact of gender and size on the pathology of small renal mass. Kaohsiung J Med Sci 28:369–372
31.
Zurück zum Zitat Xiong YH, Zhang ZL, Li YH, Liu ZW, Hou GL, Liu Q, Yun JP, Zhang XQ, Zhou FJ (2010) Benign pathological findings in 303 Chinese patients undergoing surgery for presumed localized renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 17:517–521 Xiong YH, Zhang ZL, Li YH, Liu ZW, Hou GL, Liu Q, Yun JP, Zhang XQ, Zhou FJ (2010) Benign pathological findings in 303 Chinese patients undergoing surgery for presumed localized renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 17:517–521
32.
Zurück zum Zitat Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S, Ishikawa Y, Kumagai J, Kihara K, Fukui I (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 72:598–602 Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S, Ishikawa Y, Kumagai J, Kihara K, Fukui I (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 72:598–602
33.
Zurück zum Zitat Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ (2008) Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 179:1719–1726 Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ (2008) Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol 179:1719–1726
34.
Zurück zum Zitat Siemer S, Hack M, Lehmann J, Becker F, Stockle M (2006) Outcome of renal tumors in young adults. J Urol 175:1240–1243; discussion 1243–1244 Siemer S, Hack M, Lehmann J, Becker F, Stockle M (2006) Outcome of renal tumors in young adults. J Urol 175:1240–1243; discussion 1243–1244
35.
Zurück zum Zitat McKiernan J, Yossepowitch O, Kattan MW, Simmons R, Motzer RJ, Reuter VE, Russo P (2002) Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60:1003–1009 McKiernan J, Yossepowitch O, Kattan MW, Simmons R, Motzer RJ, Reuter VE, Russo P (2002) Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. Urology 60:1003–1009
Metadaten
Titel
Gender differences in benign renal masses
verfasst von
Julian Mauermann
Michela de Martino
Matthias Waldert
Andrea Haitel
Hans Christoph Klingler
Mesut Remzi
Tobias Klatte
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1032-4

Weitere Artikel der Ausgabe 5/2013

World Journal of Urology 5/2013 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.